NCT05300048 2026-04-30Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA MutationsFaeth TherapeuticsPhase 1 Terminated34 enrolled